November 10, 2021 Comments Off on New patent for Averitas drug QUTENZA Posted in: Patent Added Annual Drug Patent Expirations for QUTENZA Qutenza is a drug marketed by Averitas and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation for…
The post New patent for Averitas drug QUTENZA appeared first on Drug…
November 10, 2021 Comments Off on New tentative approval for Radius Health drug abaloparatide Posted in: Tentative Approval Abaloparatide is the generic ingredient in one branded drug marketed by Radius Health Inc and is included in one NDA. There are four patents protecting this compound. This ingredient has…
The post New tentative approval for Radius Health drug abalopara…
